SCHEMBL9952165

SCHEMBL9952165

CC#CCc1cncc(B(O)O)c1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21994422 0.79 ENPP2 (0.56) ENPP2
SCHEMBL1303307 0.76 LPL (0.48) ENPP2
SCHEMBL15940842 0.74 ENPP2 (0.50) ENPP2
SCHEMBL29955816 0.73 ENPP2 (0.32) ENPP2
SCHEMBL931865 0.73 ENPP2 (0.32) ENPP2
SCHEMBL9951567 0.73 HTT (0.36)
SCHEMBL19009019 0.73 THRB (0.34) ENPP2
Hydrochloric Acid SCHEMBL29955592 0.72 ENPP2 (0.48) ENPP2
SCHEMBL2067301 0.71 CYP11B2 (0.42) ENPP2
SCHEMBL17847176 0.71 GABRA1 (0.34) ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655378-A1 COMPOUNDS AND THEIR USE AS BACE INHIBITORS AstraZeneca AB (SE) 2013-10-30 EP disclosed
WO-2012087237-A1 COMPOUNDS AND THEIR USE AS BACE INHIBITORS ASTRAZENECA AB (SE) 2012-06-28 WO disclosed